| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4000321 | Urologic Oncology: Seminars and Original Investigations | 2011 | 9 Pages |
Abstract
The diagnostic test, based on the three most discriminatory miRNAs in our panel (miR-200c, miR-141, and miR-30b), showed a sensitivity of 100% and a specificity of 96.2%. Such a panel of miRNAs has the potential to identify invasive bladder tumors misclassified in pathologic assessment of bladder biopsy specimens.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Matthew F. M.D., Kimberly M. Ph.D., Patrick A. M.D., Justin J. M.D., Brasil M.D., Amanda K. B.S., Tanya Ph.D., John A. M.D., Ian C. Ph.D.,